Dexcom(CH:DC4)
CH:DC4
Dexcom stock forecast
Dexcom (DC4) Stock Forecast & Price Target
0 Followers
DC4 Analyst Ratings
Strong Buy
16Buy1Hold0Sell
Based on 17 analysts giving stock ratings to Dexcom in the past 3 months
DC4 Stock 12 Month Forecast
Average Price Target
CHF81.07▲(0.00% Upside)Based on 17 Wall Street analysts offering 12 month price targets for Dexcom in the last 3 months. The average price target is CHF 81.07 with a high forecast of CHF 97.71 and a low forecast of CHF 69.21. The average price target represents a ― change from the last price of ―.
Highest Price TargetHighestCHF97.71Average Price TargetCHF81.07Lowest Price TargetLowestCHF69.21
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | Leerink Partners | CHF70.84→CHF76.54 | buy | ― | Reiterated | 11/02/26 | ||
| Christopher Pasquale | Barclays | CHF93.64→CHF97.71 | buy | ― | Reiterated | 10/30/26 | ||
| William Plovanic | Canaccord Genuity | CHF73.28→CHF78.98 | buy | ― | Reiterated | 10/30/26 | ||
| Matthew O'Brien | Piper Sandler | CHF77.35 | buy | ― | Reiterated | 10/30/26 | ||
| Patrick Wood | UBS | CHF83.05→CHF87.13 | buy | ― | Assigned | 10/30/26 | ||
| Unknown AnalystNot Ranked | Evercore ISI | CHF89.57 | buy | ― | Reiterated | 10/30/26 | ||
| Jonathan Block | Stifel Nicolaus | CHF77.35 | buy | ― | Reiterated | 10/30/26 | ||
| Josh Jennings | TD Cowen | CHF77.35 | buy | ― | Reiterated | 10/30/26 | ||
| Jayson Bedford | Raymond James | CHF76.54→CHF78.98 | buy | ― | Reiterated | 10/30/26 | ||
| Robbie Marcus | J.P. Morgan | CHF66.77→CHF69.21 | hold | ― | Assigned | 10/30/26 | ||
| Kendall Au | RBC Capital | CHF85.50 | buy | ― | Reiterated | 10/29/26 | ||
| Travis Steed | Bank of America Securities | ― | buy | ― | Reiterated | 10/23/26 | ||
| Joanne Wuensch | Citi | CHF85.50 | buy | ― | Reiterated | 10/21/26 | ||
| Larry Biegelsen | Wells Fargo | CHF73.28 | buy | ― | Reiterated | 10/14/26 | ||
| Anthony Petrone | Mizuho Securities | CHF77.35→CHF81.43 | buy | ― | Assigned | 10/13/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Unknown AnalystLeerink PartnersNot Ranked | BuyReiteratedCHF70.84→CHF76.54 | 11/02/26 | ― | ||
| Christopher PasqualeBarclays | BuyReiteratedCHF93.64→CHF97.71 | 10/30/26 | ― | ||
| William PlovanicCanaccord Genuity | BuyReiteratedCHF73.28→CHF78.98 | 10/30/26 | ― | ||
| Matthew O'BrienPiper Sandler | BuyReiteratedCHF77.35 | 10/30/26 | ― | ||
| Patrick WoodUBS | BuyAssignedCHF83.05→CHF87.13 | 10/30/26 | ― | ||
| Unknown AnalystEvercore ISINot Ranked | BuyReiteratedCHF89.57 | 10/30/26 | ― | ||
| Jonathan BlockStifel Nicolaus | BuyReiteratedCHF77.35 | 10/30/26 | ― | ||
| Josh JenningsTD Cowen | BuyReiteratedCHF77.35 | 10/30/26 | ― | ||
| Jayson BedfordRaymond James | BuyReiteratedCHF76.54→CHF78.98 | 10/30/26 | ― | ||
| Robbie MarcusJ.P. Morgan | HoldAssignedCHF66.77→CHF69.21 | 10/30/26 | ― | ||
| Kendall AuRBC Capital | BuyReiteratedCHF85.50 | 10/29/26 | ― | ||
| Travis SteedBank of America Securities | BuyReiterated | 10/23/26 | ― | ||
| Joanne WuenschCiti | BuyReiteratedCHF85.50 | 10/21/26 | ― | ||
| Larry BiegelsenWells Fargo | BuyReiteratedCHF73.28 | 10/14/26 | ― | ||
| Anthony PetroneMizuho Securities | BuyAssignedCHF77.35→CHF81.43 | 10/13/26 | ― |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Dexcom
3 Months
Success Rate27/43 ratings generated profit
63%
Average Return
+9.95%
Copying Jeff Johnson's trades and holding each position for 3 Months would result in 62.79% of your transactions generating a profit, with an average return of +9.95% per trade.
1 Year
Success Rate35/50 ratings generated profit
70%
Average Return
+36.00%
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +36.00% per trade.
2 Years
Success Rate38/50 ratings generated profit
76%
Average Return
+83.55%
Copying Steven Lichtman's trades and holding each position for 2 Years would result in 76.00% of your transactions generating a profit, with an average return of +83.55% per trade.
DC4 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 0 | 0 | 0 | 0 |
| Buy | 64 | 38 | 32 | 28 | 25 |
| Hold | 2 | 2 | 2 | 2 | 1 |
| Sell | 2 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 71 | 40 | 34 | 30 | 26 |
In the current month, DC4 has received 25 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. DC4 average Analyst price target in the past 3 months is 81.07.
DC4 Financial Forecast
HighCHF0.63
ConsensusCHF0.58
LowCHF0.55
DC4 Earnings Forecast
Next quarter’s earnings estimate for DC4 is CHF 0.58 with a range of CHF 0.55 to CHF 0.63. The previous quarter’s EPS was CHF 0.60. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighCHF1.15B
ConsensusCHF1.13B
LowCHF1.11B
DC4 Sales Forecast
Next quarter’s sales forecast for DC4 is CHF 1.13B with a range of CHF 1.11B to CHF 1.15B. The previous quarter’s sales results were CHF 1.10B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
DC4 Stock Forecast FAQ
What is CH:DC4’s average 12-month price target, according to analysts?
Based on analyst ratings, Dexcom’s 12-month average price target is CHF81.07.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Dexcom a Buy, Sell or Hold?
Dexcom has a consensus rating of Strong Buy, which is based on 16 buy ratings, 1 hold ratings and 0 sell ratings.
What is Dexcom’s share price target?
The average share price target for Dexcom is CHF81.07. This is based on 17 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF97.71, and the lowest forecast is CHF69.21. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about Dexcom?
Dexcom’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Street analysts.
How can I buy shares of Dexcom?
To buy shares of CH:DC4, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
